Clinical Trial: Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06954766) titled 'Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981' on April 24.

Brief Summary: The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Knee Osteoarthritis

Intervention: DEVICE: CKD-981(1)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE: CKD-981(2)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE: Sham device

20 minutes per day, 5 days a week for 6 weeks.

DRUG: Active comparator

QD for 6 weeks

DRUG: Placebo

QD for 6 weeks

Recruitment ...